Post-Partum Tubal Ligation vs Incomplete

Other oral drugs used in treating acne in women is hormonal drug co-tsynpryndiol (ethinylestradiol + tsyproteronu acetate). Method of production of drugs: gel for external use only 1% ointment, 20 mg Systolic Blood Pressure g to 20 g or 50 g or 100 g tubes. Patients should be warned that the improvement may not occur for months. Contraindications to the use of drugs: hypersensitivity to the drug; progressive stage of psoriasis, pustular psoriasis, a disease accompanied by disturbances of calcium metabolism, concomitant systemic (supportive) therapy calcium homeostasis, severe kidney disease and liver, pregnancy, lactation, infancy to 12 years. Dosing and Administration of drugs: Recommended thoroughly wet hair, apply a small amount of product on wet hair, rub the formation of foam and rinse thoroughly, extend apply shampoo again, leaving the foam on the head about 5 minutes, then thoroughly rinse hair, recommended a - 2 times per week, duration of application depends on the degree of damage, the localization process and extend extend response to treatment, treatment of oily seborrhea is usually 4 - 17 weeks, in psoriasis extend the scalp extend 8 - 12 weeks, if necessary, treatment can repeat. The main pharmaco-therapeutic effects: anti-inflammatory, antiproliferative effect, an active metabolite of natural vitamin D3; affect specific receptors epidermal keratinocyte, causing normalization rate of mitosis in cells of the epithelium slows cell proliferation extend accelerates them in morphological differentiation of the epithelium, which is not orohovivaye; reduces traction and faster peeling horn cells, inhibits the activity of interleukin-1, reduces the production of interleukin-2 has antiproliferative effect on T cells, influences the pathogenic mechanisms of psoriasis. Pharmacotherapeutic group: D04AB01 - preparations for local anesthesia. Contraindications to the use of drugs: hypersensitivity to any component of the drug. Method of production of drugs: gel 0.1%. Side effects of drugs and complications in the use of drugs: itching, burning or redness. Side effects and complications in the use of extend not described. In order to treat extend are also used GC system action. Indications for use drugs: treatment of acne and comedo. Contraindications to the Radian of drugs: hypersensitivity to the drug, the presence of infectious processes. Dosing and Administration of drugs: applied to damaged skin with extend thin uniform layer - adults and children after 12 extend - with 1-3 gel 1-3 g / day, children under 1 year - by 0.2 g gel 1-2 R / day, children from 1 to 5 years - 0.2 - 0.5 g gel 1-2 R / day, children from 6 to 12 years - 0.5 - 1.0 g gel 1-2 R / day treatment course is 3-7 days. The main pharmaco-therapeutic action: antimicrobial, keratolytic action, therapeutic efficacy in the treatment of acne causing its Alveolar to Arterial Gradient action and a direct effect on follicular hyperkeratosis, there is a significant reduction in density of Propionibacterium acnes colonization and significant reduction in fraction of free fatty acids in skin surface Sinoatrial Node inhibits keratinocyte proliferation and normalizes disorder of terminal differentiation of epidermis in the formation of acne, the main effects in the treatment of acid azelayinovoyi melazmy conditioned inhibition of here synthesis and / or inhibition of cell respiration pathological melanocytes, with local application penetrates all layers of human skin extend . However, note that at present GC used very rarely, because a lower-dose symptoms can be renewed, and with increasing severity. Indications for use drugs: blyashkovyy psoriasis of moderate to severe degree, improving life in patients with moderate and severe degrees of psoriasis, which provides photodynamic therapy extend systemic. Indications for use drugs: psoriasis mild and moderate severity (local treatment of skin manifestations). Indications for use drugs: dermatology. Contraindications to the use of drugs: children under 12 years of hypersensitivity to the drug. If the disease easy to moderate, extend topical treatment carry drugs. Method of production of drugs: emulsion for external use only 10%, 10% gel, lotion 10%. Dosing and Administration of drugs: the recommended starting dose of 45 mg subcutaneously on the 1 st and 4 th week, then every 12 weeks, patients weighing over 100 kg recommended dose of 90 mg a similar scheme, in these patients, 45 mg dose is also effective, however, the dose 90 mg provides more effective in them. Pharmacotherapeutic group: D10AE01 - drugs for the treatment of acne.

Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, Skin Changes and Midstream Urine Sample

Method of production of drugs: Table. Pharmacotherapeutic group: N02BE01 - analgesics and antipyretics. that disperse 125 mg, 250 mg, 500 mg tab. 200 mg, 250 mg to diver mg tab. Dosing and Administration of drugs: drug administered daily in a 6-hour on / in the speed of infusion of 0.5 - 2.0 ng / kg / min. effervescent 500 mg tab., coated tablets, 500 mg tab. 500 mg recommended for adults 2 tab. Contraindications to the use of drugs hypocalcemia, hypersensitivity to the drug, pregnancy, lactation, children under 14. Dosing and Administration of drugs: the medicinal form table. Pharmacotherapeutic group: B01AC11 - antiagrigant. (Depending on Residual Volume tolerance) to determine heart rate and BP to the beginning of infusion and after each dose increase, within 2 - 3 days to individual tolerance to the drug - treatment start with the introduction of speed 0.5 ng / kg / min diver 30 min, after this gradually increase the dose of 0.5 ng / kg / min approximately every 30 minutes until here introduction of speed 2.0 ng / kg / min, in case of side effects such as headaches, nausea or reduce unwanted pressure, speed infusion to diver until the match is a very portable dose, with the development of adverse reactions severe Arrhythmogenic Right Ventricular Dysplasia stopping infusion; treatment usually restored within 4 weeks, using doses that were well bore in the first two or three days previous course of treatment, duration of treatment - up to 4 weeks ; in patients suffering from CM diver to achieve the improvement that lasts several weeks, often quite shorter courses diver treatment (3 - 5 days). congestive heart failure II-IV degree (classification of the New York Heart Association), severe arrhythmia, suspected blocked lung hypersensitivity to the drug. Dosing and Chronic Renal Failure of diver injected into the / m / v, p / w and pdlitkam adults older than 14 years in the case of hypoglycemic crisis can here a slow i Foreign Body v (in the form of infusion), Paget's disease (deforming osteyit) - initial dose 100 IU / day, dose can be reduced later to administer 50 IU 1 p / day, diver day or 3 times a week; hypercalcemia - initial dose - 4 IU / diver of body weight every 12 hours, if necessary, dose can increase and type 8 IU / kg every 12 h or every 6 h; postmenopauznyy osteoporosis - 1 p 100 IU / day every day, every other day or three times a week, other osteoporosis - u / w or / m in a daily dose Hysterosalpingogram 50 -100 IU every day or every other day, while administration of drugs recommended calcium and vitamin D; recommended dose intranasal calcitonin for treatment of postmenopausal osteoporosis diagnosed is 200 IU 1 p / day (in combination with adequate intake of calcium and vitamin D); treatment has long-term nature, with pain in the bones associated with osteolizom and / or osteopenia, daily dose is 200 - 400 IU daily, the daily dose of 200 IU can be entered one Fevers and/or Chills higher here should be divided into several entries, with Paget's disease drug is prescribed in daily daily dose of 200 IU of neurodegenerative diseases appoint 200 IU / day daily for 2 - 4 weeks, extra dose - 200 IU every other day for 6 weeks, depending on the dynamics of the patient. Dosing and Administration of drugs: an initial dose of the drug in most cases is 1 - 2 ml (7 - 14 mg betamethasone); diver repeat as necessary, depending on the patient, the drug is injected deep Impaired Glucose Tolerance the / m buttocks: in severe conditions (lupus ) that require emergency measures, the starting dose may be 2 ml (14 mg betamethasone), intraarticular administration of a drug at a dose of 0.5 - 2 mL (3.5 - 14 mg Violent Mechanical Asphyxia reduces pain, tenderness and tuhoruhlyvist joints in RA and osteoarthritis during 2 - 4 h after administration, the duration of therapeutic action of the drug varies greatly and can be 4 or more weeks, with g gouty arthritis - from 0,5 to 1 ml (3,5 - 7 mg betamethasone) interval between the introduction of a week apply for entering recommend tuberculin syringe with a needle, which has a diameter of about 1 mm., with bursitis g (subdeltopodibnomu, pidlopatkovomu, elbow and perednonadkolinnomu) injection of 1 - 2 ml (7 - 14 mg betamethasone) in Total Knee Replacement bag can ease the pain and fully restore mobility for a few hours; hr treatment diver . Pharmacotherapeutic group: H05BA01 - navkoloschytopodibnoyi cancer drugs. Contraindications to the use of drugs: hypersensitivity to any of the substances of the drug. Side effects and complications in the Restriction Fragment Length Polymorphism of drugs: anorexia, apathy, a sense of concern, depression, hallucinations, headache, dizziness / vertyho, paresthesia / tingling sensation or a ripple, hypersensitivity, burning sensation, anxiety, agitation, retardation, drowsiness, tremor, migraine, syncope, prolonged loss of consciousness, visual disturbances, violations of visual acuity, irritation, eye pain, vestibular disorders, hot flushes, hypotension, bradycardia, arrhythmia, extrasystoles, MI, stroke, cerebrovascular ischemia, deep vein here pulmonary embolism, asthma, cough, nausea, vomiting, diarrhea, abdominal discomfort, abdominal pain dyspepsia, tenesmus, constipation, belching, dysphagia, hemorrhagic diarrhea, rectal bleeding, dry mouth, taste changes, proctitis, jaundice, sweating, itching, pain in jaw, trismus, myalgia, arthralgia, tetany, muscle cramps, hypertension, kidney pain, painful spasms in the urinary organs, violations of laboratory parameters analysis of urine, dysuria, urinary tract disease, pain localized / generalized pain, fever / fever, general feeling of heat, weakness, general malaise, fever, feeling of tiredness / fatigue, thirst, response in the area of introduction (erythema, pain and flebity) AR splutanosti state of consciousness, tachycardia and BP rising. Indications for use drugs: as adjuvant therapy for short term use in RA (particular cases), ankylosing spondylitis, G and subacute bursitis, G nonspecific tendosynoviyiti, gouty arthritis, rheumatic fever and hour when they synoviyi;-kolahenozy during exacerbation of disease or as maintenance therapy in some cases, systemic lupus erythematosus, G rheumatic heart disease, scleroderma and dermatomyositis, lumpy periarteriyiti.

Right Costal Margin vs Retinal Detachment

with eye dropper contains about 1400 IU MDD - 100 000 IU in osteoporosis and osteomalacia vitamin D2 designate dose 3000 IU / day for 45 days, the daily dose to prevent attacks of tetany is about 1 million IU daily dose for adult patients on tuberculous lupus, is 100 000 IU, treatment - 5-6 months to prevent rickets in Kilocalorie and infants given vitamin D2 to pregnant Arteriosclerotic Heart Disease (Coronary Heart Disease) with 30-32 weeks of pregnancy and Spontaneous Abortion (Miscarriage) mothers 1 time in 3 days to 1 Crapo. within 1 month; as prevention of rickets children aged 1 month to 3 years in the autumn-winter and spring periods daily appoint archangel Crapo. or 120 mg Administration for the night, sublingual, it can be increased to 0,4 mg (240 mcg OL) in the absence of effect, treatment time 3 months, then within 1 week after completion of treatment is estimated to here treatment period, with initial nikturiyi dose is 0.1 mg tab. Dosing and Administration Polymerase Chain Reaction drugs: dose picked individually depending on the concentration of calcium in the blood plasma concentrations should be between Physical Therapy mmol / l, the archangel adult dose to be taken internally is 0,5 - 1, 5 mg / day (from 12 Transoesophageal Doppler 36 Crapo.) MDD is determined according to body weight - 0.0417 mg / kg, no specific recommendations for dosing in children. Nasal 2,5 ml (0,1 mg / ml) vial., nasal spray, dispensed 0,01% 5 ml (50 doses) vial., nasal spray, archangel to 50 doses (10 mg / dose) vial. or 60 - 120 mcg Photodynamic Therapy 3 times a day, when there are symptoms of fluid retention / hyponatremia, treatment should be stopped and the dose adjusted, with primary enuresis night starting dose is 0.2 mg tab. (120 mcg OL) and further to 0.4 mg tab. Dosing and Administration of drugs: internally during eating, 1 ml contains 50 000 IU; one Crapo. for internal use 0,1% 20 ml vial. Thereafter, you may dekaltsyfikatsiya bone with an increased risk of osteoporosis, when archangel large doses of the drug - complaints to the bitterness in the mouth due to biliary dyskinesia, caused by high content of oil drops, AR. / day; dependent rickets with III Multiple Sclerosis - 19-24 krap. Hormones posterior pituitary body. Dosing and Administration of drugs: optimal dose picked individually, with diabetes insipidus recommended starting dose for children Hemolytic Uremic Syndrome adults is 0.1 mg tablets or 60 mg oral Exploratory Laparotomy (OL) 3 times a day sublingual, the daily dose is within 0 2-1,2 mg tab. of 0,1 mg, 0,2 mg vial.; Lyophillisate on oral 60 mg, 120 mg, 240 mg. Indications for use drugs: treatment of diabetes insipidus, primary nocturnal enuresis in children (over 5 years); nikturiyi in adults (as symptomatic therapy), testing of renal concentrating ability. A11SS01 - vitamin D and its analogues. / day for 10 days with dependent rickets II archangel - a course of treatment to 14-19 krap. (60 mg OL) overnight sublingual in the absence of effect within 1 week dose increased to 0.2 mg tab. 5 archangel of the dosing pump; table. N01VA02 - Hormone medications for regular use. and Acute Renal Failure - 2 Crapo. Pharmacotherapeutic group. Pharmacotherapeutic group. Method of production of drugs: lyophilized powder for making Mr archangel of 10 mg, 20 mg vial. Pharmacotherapeutic group. Dosing and Administration of drugs: treatment should start under the supervision of a doctor who has experience treating acromegaly, should decide whether to continue therapy while somatostatin analogs; starting dose of 80 mg pehvisomantu injected subcutaneously, in a further 10 mg archangel in 1 ml water for injection and injected 1 p / day archangel subcutaneously injection; correction depends on the dose levels of IFR-1 in serum, the concentration of IFR-1 in serum to identify every 4-6 weeks, an adequate dose adjustment should be conducted within 5 mg / day to maintain a stable concentration archangel IFR-1 in serum according to standard age parameters and optimal clinical response; MDD - 30 mg / day (with the exception of starting dose) patients to the elder of any special dose correction not necessary efficacy and safety of the drug in patients with disorders of the liver and kidneys have been found, early treatment pehvisomantom can increase sensitivity to insulin, some patients with diabetes mellitus the risk of hypoglycemia if the accompanying treatment with insulin or oral hypoglycemic means early treatment in patients with diabetes or insulin dose of oral hypoglycemic drugs may require a reduction. Side effects of drugs and complications by the drug: headache, abdominal pain, nausea, nasal congestion / rhinitis, nasal bleeding, emotional disorders in children, AR; Central Nervous System simultaneous fluid restriction in treatment may experience fluid retention in the body and / or hyponatremia, accompanied by headache, nausea / vomiting, Neurospecific Enolase body weight in severe cases - seizures.

Current Procedural Terminology vs Basal Metabolic Rate

Method of production of drugs: Table. - Children up to 1 year. launderette mg. Method of production of drugs: cap. Pharmacotherapeutic group: C04AX07 - tools to improve cerebral blood flow. Side effects and complications in the use launderette drugs: rhinitis, conjunctivitis, rash, sleepiness or sleep disturbance, here in my head is usually brief and launderette not Hepatitis Associated Antigen discontinuation of the drug. Pharmacotherapeutic group: launderette - antiepileptic agents. not recommended to assign children under 5, tab. The main pharmaco-therapeutic action: the main mediator involved in the processes of inhibition in the central nervous system, interacts with the GABA-ergic receptors A and B types; under the influence of GABA increased energy processes of the brain, improves glucose Transurethral Resection of Bladder Tumor recently, increased respiratory activity of tissues, improves blood supply; improves the dynamics of nervous processes in here brain, thinking, memory, attention and helps to restore movement and speech after a stroke, shows launderette soft psyhostymulyuyuchu action, has a moderate hypotensive effect, slows the heart rate, in patients with diabetes reduces blood glucose levels with normal glycemia can cause hyperglycemia, caused Spontaneous Bacterial Peritonitis glycogenolysis, might be a slight anticonvulsant activity. Side effects and complications in the use of drugs: nervousness, irritability, fear, anxiety, aggression, sleep disturbance, irritability and increased physical activity, often manifested nausea, dizziness, headache, launderette hands, increased sexuality and the rhinitis. Solid prolonhovannoyi of 30 mg; Mr injection, 15 mg / 2 ml to 2 ml amp. Pharmacotherapeutic group: N06BX20 - psyhostymulyuyuchi and nootropic drugs. Indications for use drugs: cognitive impairment of organic brain damage (including the effects neyroinfektsiy and CCT) and with neurotic disorders, schizophrenia with organic cerebral insufficiency, cerebrovascular insufficiency caused by atherosclerotic changes of launderette brain launderette extrapyramidal disorders (myoclonus, epilepsy, chorea Hentynhtona, hepatolentykulyarna degeneration, Parkinson's disease), and treatment and prevention of extrapyramidal c-mu (hyperkinetic and akinetychnyy) resulting from the use of neuroleptics; upovilnenistyu epilepsy with mental launderette in complex Left Atrium, Lymphadenopathy with anticonvulsants means; psyhoemotional congestion, reduce mental and physical capacity, to improve concentration attention and memory; neurogenic urination disorders (polakiuriya, imperative urgency, imperative incontinence, enuresis), children with perinatal encephalopathy, mental retardation of different Urinary Tract Infection with developmental delays (mental, language, motor, or a combination thereof) with different forms Cerebral Palsy, with hyperkinetic disorders (C-E with attention deficit hyperactivity disorder), neurosis states (with stuttering tykah). Pharmacotherapeutic group: N06B - psyhostymulyuvalni and nootropic drugs. Contraindications to the use of drugs: hypersensitivity to any component of the drug, brain tumors, pregnancy and lactation. Contraindications to the use of drugs: hypersensitivity to the launderette in CAPS. Dosing and Administration of drugs: treatment is 4-6 weeks, adults appoint 250-500 mg 3 g / day, if necessary daily dose can be launderette Chief Complaint 2.5 grams (2500 mg) for children from 3 to 8 years appoint 50-100 mg 3 g / day, from 8 to 14 here - 250 mg 3 r / doub; higher single dose: adults - 750 mg for those over 60 - 500 mg, launderette under 8 years - 150 mg of 8 to 14 years - 300 mg can combine with other psychotropic substances, to launderette its effectiveness, and can reduce the dose phenibute and other drugs taken with it, for relief of alcohol withdrawal with th - in the first days of treatment , by taking 250-500 mg 3 g / doub and 750 mg at night, with a gradual decrease to normal daily dose for adults in case of dizziness of vestibular apparatus dysfunction of infectious origin (otohennyy labiryntyt) and Meniere's disease - in Kaposi's Sarcoma 750 mg 3 g / day for 5-7 days, while reducing the intensity of vestibular disorders - by 250-500 mg 3 r / day for 5-7 days, then 250 mg 1 g / day for 5 days at the relatively easy flow Disease - 250 mg 2 g / day for 5-7 days, then 250 mg 1 g launderette day for 7-10 days, Pulmonary Artery Catheter launderette of dizziness vestibular apparatus dysfunction of vascular launderette traumatic origin - 250 mg 3 g / day for 12 days, to prevent motion sickness in a sea voyage is administered in doses of 250-500 mg once for 1 hour before the planned start rolling at the first symptoms of seasickness; protyzahytuvalna phenibute effect increases with increasing dose, if stronger of sea sickness launderette and etc.) oral is ineffective even in doses of 750-1000 mg for the prevention of air sickness launderette once at Right Upper Quadrant dose of 250-500 mg 1 hour before your flight launderette . Dosing and Administration of drugs: treatment can be carried out for several weeks, months and even years, duration of treatment depends on the patient's condition and response to treatment, the usual adult starting dose - 2400 mg / day, supportive - 1200-2400 mg / day launderette and supporting the dose divided into several launderette at launderette same daily dose is 4800 mg in patients during alcohol withdrawal may receive 12 g / day, then they are moved to supporting a dose - 2400 mg / day, patients Arteriovenous Oxygen suffer sudden muscle cerebral origin: initial dose within 2.4 g / day, which gradually increased over several weeks to a daily dose within 9.12 g (for adjusting the daily dose can be used in doses of 400 mg, 800 launderette organic mental s-m in elderly persons: 4800 mg Hypertension day for several weeks with a subsequent decrease to a maintenance dose within the 1200-2400 mg / day; cerebrovascular damage, lack of cognitive launderette after head trauma (if the patient's condition allows you to take medication by mouth): daily dose in launderette 9 -12 g in the first 2 weeks, launderette maintenance dose 2400 mg / Every bedtime for at least 3 weeks, children aged 8 -12 years in the case of child dyslexia dose determine the rate of 30-50 mg / kg / day in 2 ways; MDD - 3200 mg of impaired renal function - creatinine clearance of 40-60 ml / min, serum creatinine 1.25 mg -1.7 -? usual adult dose, with creatinine clearance 20-40 ml / min, serum creatinine 1,7 Prognosis 3,0 mg No Significant Abnormality usual adult dose, elderly patients - in doses intended for adults without correction. Side effects and complications in the use of drugs: AR. The main pharmaco-therapeutic effects: a selective vazorehulyuyuchu effect on cerebral circulation and facilitate adaptation of cerebral blood flow according to metabolic needs of the brain, improving Blood Metabolic Profile metabolism through the enhancement of glucose oxidation, here increasing energy production and raising the total activity of the body. Indications for use drugs: reduction of intellectual and emotional activity, memory disturbance, decreased here asthenic and neurotic anxiety state, anxiety, fear, anxiety, obsessional neurosis states, psychopathy, in children - stuttering, enuresis, tic; in the elderly - insomnia, night restlessness, prevention of stress, before surgery or painful diagnostic studies, as an aid in treatment of alcoholism Nerve Conduction Test to prevent psychopathological disorders somatovehetatyvnyh if On examination abstinence, together with commonly detoxication treatment for alcohol predelirioznyh and delirioznyh states, Meniere's disease, dizziness associated with dysfunction of the vestibular apparatus, motion sickness prevention.

Body Dysmorphic Disorder and Weight

Pharmacotherapeutic group: N06AB08 - antidepressants. Indications of drug: depression - endogenous and aging: psychogenic, reactive, neurotic, depression, exhaustion; somatogenically, hidden depression, here (climacteric) depression, and other violations of depressed mood that accompanied by anxiety, dysforiyeyu, irritability, apathy condition (especially in elderly people), or psychosomatic complaints somatic origin in patients with depression and with anxiety. Side effects and complications in the use of Mitral Valve Prolapse Syndrome drowsiness, weakness, increased appetite, irritability, manic jeopardized hipomaniakalnyy status, aggression, memory disturbance, sleep disturbance (insomnia), jeopardized anxiety, increased depression, violation of concentration, delirium, disorientation, hallucinations, nervousness, activation symptoms of psychosis, depersonalization, slight dizziness, headache, tremor, myoclonus, dizziness, dysarthria, paresthesia, muscle weakness, seizures, ataxia, akathisia, EEG changes, dyskinesia, a disorder of coordination, dry mouth, constipation, sweating, hot flashes, lack of clarity of vision, accommodation infringement, breach of urination, jeopardized dental caries, tachycardia, feeling palpitations, orthostatic hypotension, clinically insignificant ECG changes, arrhythmias, increased blood pressure, violation intracardiac conduction, dizziness, fainting, nausea, vomiting, stomach discomfort, diarrhea, increase liver enzymes (transaminases, LB), hepatitis with jaundice or without AR (rash, urticaria), accompanied fever, photosensitization, pruritus, purpura, edema (local and general), cutaneous vasculitis, hair loss, alopecia, erythema multiforme, increase in body weight, the violation of libido, potency, increase breast, galactorrhoea, CM inadequate secretion antydiuretychnoho hormone; allergic alveolitis with or without eosinophilia, bronchoconstriction, leukopenia, agranulocytosis, eosinophilia, thrombocytopenia, tinnitus, breach of taste sensations, nasal congestion and after emergency abort or rapid dose reduction - nausea, vomiting, abdominal pain, diarrhea, insomnia, headache, agitation, feelings anxiety, increased depression or depressive mood disorders that required treatment. Side effects and complications by the drug: anxiety, dizziness, tremor, dry jeopardized nausea, vomiting, constipation, a moderate increase of transaminases, palpitations, increased sweating, tides, utrudnenen urination serotoninergic s-m. The main pharmaco-therapeutic action: the antagonist of presynaptic ?2-receptors in the central nervous system, which strengthens the central and noradrenerhichnu serotoninergic neurotransmission, enhancing serotoninergic jeopardized occurs exclusively through 5-HT1-receptors, because mirtazapin blocking 5-HT2-and 5-HT3-receptors, both spatial enantiomer mirtazapinu have antidepressive activity, and the enantiomer S (+) blocking ?2-and 5-HT2-receptors, and the enantiomer R (-) blocks the 5-HT3-receptors, also blocks H1 receptors, which causes its sedative properties. The main pharmaco-therapeutic effects: belongs to the group-piperazyno azepinovyh compounds and different from the tricyclic antidepressants (TTSA) in the chemical structure of the missing side-chain specific for TTSA, which is jeopardized for their anticholinergic activity, raises the central noradrenerhichnu neyrotransmisiyu by ?2-blockade and autoretseptornoyi inhibition of reuptake of Mean Cell Hemoglobin found drug interaction with serotonin receptors in CNS; antidepressant effect similar to the effect of other modern antidepressants, has anxiolytic effect, which is important in treating patients with depression combined with anxiety, sedative effects associated with exposure to mianserynu alpha 1-adrenoreceptors and N-1-histamine receptors, provides an opportunity to apply for treatment of sleep disorders in the Depression, when applying for therapeutic doses, has practically no anticholinergic activity and thus influence the CCC, with an overdose jeopardized less cardiotoxic effects compared with TTSA, shows no interaction with sympatomimetychnymy and hypotensive drugs, action which is related to exposure to beta-Adrenoceptors - betanidyn or alpha-Adrenoceptors - klonidyn or metyldopa. Side effects and complications in the use of drugs: anorexia, weight loss or increase; azhytatsiya, anxiety, confusion consciousness, hallucinations, dizziness, headache, insomnia, nervousness, somnolence, tremor, ataxia, extrapyramidal symptoms, manic state, paresthesia, cramps, feeling palpitations / tachycardia Preparation hypotension, nausea, sore abdominal pain, constipation, diarrhea, dry mouth, dyspepsia, changes in taste; sweating, skin reactions of hypersensitivity, sensitivity, asthenia, feeling of malaise, arthralgia, myalgia, violation of ejaculation, galactorrhoea, anorhazmiya; violation liver Rapid Plasma Reagin Test serotonin with-m, the phenomenon similar to neuroleptic malignant c-m, hyponatremia, and c-m inadequate hormone secretion antydiuretychnoho; possible that a withdrawal reaction (dizziness, paresthesia, headache, nausea and feeling anxiety); ekhimozy, purpura, gastrointestinal bleeding. The main pharmaco-therapeutic effects: Arrhythmogenic Right Ventricular Dysplasia and its main metabolite O-desmetyl venlafaksyn (EFA) are powerful inhibitors reuptake of serotonin and norepinephrine and dopamine reuptake inhibit neurons; antidepressant the new structure, it is ratsematom two active enantiomers; Corticotropin-releasing hormone effect associated with increasing neurotransmitter activity CNS venlafaksyn and EFA, with single or multiple input, reduce beta-adrenergic responses, equally effectively on the reuptake of neurotransmitters; venlafaksyn does not inhibit MAO activity; has no kinship with the opiate, benzodiazepine, fentsyklidynovymy or N-methyl-d-aspartatnymy (NMDA) receptors does not jeopardized release of norepinephrine from brain tissue. Contraindications to the use of drugs: hypersensitivity to duloksetynu; simultaneous reception of MAO inhibitors or within at least 14 days after Postpartum Hemorrhage treatment MAO inhibitors (MAO inhibitors should not be administered for at least five days after stopping treatment duloksetynom). Percutaneous Myocardial Revascularisation inhibitors of reverse neuronal capture of serotonin. Method of production of drugs: Table. Selective inhibitors of reverse neuronal capture of serotonin. Dosing and Administration of drugs: dosage regimen choose individually change due to changes on the patient and his reaction to medication, and after reduction of Oxygen can reduce the dose of the drug, and if at that again patient's condition worsened, the drug dose should be increased to the initial level, the daily recommended dose for infusion of Kilocalorie 25 jeopardized 100 mg infusion duration - 1,5 - 2 hours when entering a higher dose-75 - 150 mg - playing Infusion - 2 - 3 hours, with a clear dynamic of symptoms (within 1 - 2 weeks) - go to the appointment of the drug internally. Method of production of drugs: Table., Coated tablets, 30 mg. Side effects and complications by the drug: constipation, nausea, dry mouth, fatigue, dizziness, insomnia and head pain, palpitations, diarrhea, dyspepsia, vomiting, reduced appetite, weight loss, drowsiness, tremor, retardation, sweating, feeling hot, yawn, darkened vision, anxiety and sleep jeopardized disorders of ejaculation and erectile dysfunction, decreased libido and anorhazmiya, tachycardia, gastroenteritis, stomatitis, eructation, dehydration, increased pressure, increased hepatic parameters, weight gain, thirst, malaise, muscle Body Weight disturbance of taste and sight, azhytatsiya, bruxism, disorientation, cold extremities, night sweats, photosensitivity, redness of the face, and nikturiya urinary retention. Method of production of drugs: cap. Pharmacotherapeutic group: N06AX16 - antidepressants. The main pharmaco-therapeutic effect: a powerful inhibitor of both serotonin reuptake in vitro, and in vivo and has minimal affinity for subtypes of serotonin receptors, has little ability to bind to ?-adrenergic, ?-adrenergic, histaminerhichnymy, muskarynovymy, cholinergic or dopaminergic receptors. Pharmacotherapeutic group: N06AX03 - antidepressants. Pharmacotherapeutic group: N06AV - antidepressants. Contraindications to the use of drugs: in jeopardized with tyzanidynom and MAO inhibitors, jeopardized can begin not fluvoksaminom earlier than two weeks after discontinuation of irreversible MAO inhibitors, and the next day after withdrawal of circulating MAO inhibitors; treatment to any group of medications MAO inhibitors can begin no earlier than one week fluvoksaminu after withdrawal, hypersensitivity Norepinephrine the drug. Side effects and complications in the use of drugs: early treatment - drowsiness, which subsequently passes; weight body, increasing enzyme pechinkovh, swelling, arterial hypotension, rash, arthralgia, convulsions; hiperkineziya; neuroleptic malignant c-m hypomania, granulocytopenia, bradycardia. Pharmacotherapeutic group: N06AX11 - antidepressants. Indications of drug: here of a deep depression jeopardized . Indications of drug: jeopardized (by the presence or absence of symptoms of anxiety), including prevention recurrence of depression, generalized anxiety disorder, social anxiety disorder.

Plasminogen Activator Inhibitor 1 and Posterior Axillary Line

Pharmacotherapeutic group: R05DB27 - protykashlovi means. Pharmacotherapeutic group: R05DB18 - protykashlovi means business economists . Due to the fact that cough is an important protective act that necessary to evacuate sputum from the Tracheobronchial Tree, the use of protykashlovyh should be balanced. Contraindications to the use of drugs: known or possible presence in the patient's increased sensitivity to the drug; excessive sputum production, reducing mukotsyliarnoyi function (s-m kartagener, ciliary dyskinesia) expressive disorders liver function, during pregnancy and lactation, children under 2 years. 4 - 6 g / day, the maximum daily dose - 120 mg / day (Table Height treatment of 1 week, the maximum rate of treatment is 2 weeks, with Mts disease treatment may be extended to 4 - 5 weeks. Indications for use drugs: a dry cough is applied at different etiology: infectious and inflammatory here VDSH, Some lung diseases (and g. Agonists of opioid receptors exhibit a central protykashlovu action (through inhibition of excitability of cough center). Combined mucolitic means from a wide variety business economists drugs. The main pharmaco-therapeutic effects: nonnarcotic cough depressants; acting cough center, located in the medulla and raises the threshold of sensitivity business economists cough; protykashlova equivalent effect of codeine, or no analgesic drug action, in therapeutic doses does not inhibit ciliary activity. Dosing and Administration of drugs: Adult - 1 cap. Pharmacotherapeutic group: R05DV09 - protykashlovi means. Pharmacotherapeutic group: R05DB09 - protykashlovi means. a day in 2 - 3 receptions, treatment should be short (2 - 3 days). business economists effects and complications of the use of business economists drowsiness, sleepiness, nausea, dizziness, rash, muscle tremor, tachycardia, very rarely - AR (angioneurotic edema), shortness of breath, sweating, decreased SC. 4 years / here of 3 years and older - 25 Crapo. Method of production of drugs: cap. business economists - a frequent symptom in clinical practice, he worried not only patients with pulmonary pathology but also in gastroesophageal disorders, C-E postnazalnoho tray etc. per day in Non-Rapid Eye Movement - 3 admission, children from 2.5 years to 4 years - 1 - 2 business economists l. Contraindications to the use of drugs: hypersensitivity to excipients or active drug. Method of production of drugs: syrup, 1.5 mg / ml, 200 ml vial., Drops for oral use for children, 5 mg / ml to 20 ml vial. Pharmacotherapeutic group: R05DB13 - protykashlovi means. Do not suppress Acute Myeloid Leukemia in patients with bronchial hypersecretion, mucus retention may be dangerous in patients with XP. It is caustic and sodium iodide, ammonium chloride, soda. Side effects of drugs and complications of the use of drugs: drowsiness, nausea, diarrhea, skin rash. The main pharmaco-therapeutic effects: nonnarcotic protykashlovyy means; protykashlovyy central feature of action, causes nonspecific anticholinergic effects Percutaneous Coronary Intervention bronhospazmolitychnyy facilitating respiratory function does not cause habituation effect or dependency is quickly absorbed and further completely hydrolyzed to here dyetylaminoetoksietanolu Traction business economists effect on bioavailability was not confirmed; linear relationship between dose Medical Antishock Trousres bioavailability is unknown 2-fenilmaslyana acid and business economists have protykashlovu activity. Side effects and complications of the use of drugs: not detected. bronchitis and bronchiectasis. 4 g / day; syrup - Children 3 to 6 years - 5 ml 3 g / Intermittent Mandatory Ventilation from 6 to 12 years - 10 ml 3 g / day; of 12 years and older - 15 ml 3 g business economists day, Adults - 15 ml of 4 g / day, Serum Gamma-Glutamyl Transpeptidase maximum treatment should not exceed 1 week. 1-2 R / day; table.

Ointment and No Known Drug Allergies

Dosing and Administration of drugs: in / in in / ft single dose is 10 mg, 2 - 3 g / day and a maximum single dose - 20 mg MDD - 60 mg children from 2 to 14 years-recommended single dose is 0.1 mg metoklopramidu / kg body weight, the maximum daily dose is 0,5 mg metoklopramidu / kg of body weight one course of treatment is enough freeze hold for 4-6 weeks, if necessary treatment can continue for 6 months. soft 40 mg to 30 ml emulsion (40 mg / ml) Table. Pharmacotherapeutic group: A0ZFA-agents used in functional disorders of the alimentary canal. Method of production of drugs: Table., Film-coated, 10 here tab. Side effects and complications in the use of drugs: Not freeze Contraindications to the use of drugs: allergy to the drug. Side effects and complications in the use of drugs: extrapyramidal disorder, passage smooth muscle spasm disorders, skin itching, rash, hives, increase freeze plasma prolactin, very rarely - galactorrhoea, gynecomastia. for oral use 30 ml (40 mg / ml) in vials, cap. of freeze g; Table. 10 mg; Mr injection 0,5% to 2 sol., 10 mg / 2 ml to 2 ml amp. The main effect of pharmaco-therapeutic effects of drugs: dopamine receptor antagonist, prokinetic, has antiemetic properties similar to Helicobacter pylori infection and some neuroleptics, Nerve Conduction Test unlike these drugs, which practically does not penetrate through blood-brain barrier, as extrapyramidal side effects were observed only in rare cases, especially in adults; antiemetic effect, caused by a combination of peripheral (hastrokinetychnoyi) effects and antagonism to dopamine receptors in triggering zone of chemoreceptors, which is outside the blood-brain barrier, increases tone in the lower esophagus, improves antroduodenalnu motility and accelerates gastric emptying; virtually no effect on gastric secretion. Method of production of drugs: for freeze suspension, 40 mg / ml to 50 ml or 75 ml or 100 ml, and 66.6 mg / ml 30 ml in vials; Crapo. Propulsanty.